Medication info
Jepito Tablets 10/20 Milligrams

Jepito Tablets 10/20 Milligrams

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium›21.7mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle
Approval status
Active

MFDS item code 202100242 · Approved 2021.01.08 · Insurance code 640007730

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who uses it
Adults
Adult dosage
Administer once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/10mg∼10/40mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL-cholesterol
  • increased Apo B
  • increased triglycerides
  • increased non-HDL-cholesterol
View approved original text

This medication is used as an adjunct to dietary therapy in patients with primary hypercholesterolemia and mixed dyslipidemia to lower elevated total cholesterol, LDL-cholesterol, Apo B, triglycerides, and non-HDL-cholesterol levels while increasing HDL-cholesterol levels. It is administered alongside an appropriate diet that mainly includes restrictions on saturated fats and cholesterol, and is utilized when dietary control and other non-drug treatments alone are insufficient. This medication is used for individuals at high risk of atherosclerotic vascular disease due to hypercholesterolemia, and it is important to identify and manage secondary causes that induce dyslipidemia, such as diabetes and hypothyroidism, prior to administration. Key lipid tests to monitor during treatment include total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides. Additionally, if acute coronary events occur, lipid levels should be quickly assessed to help establish an appropriate treatment plan. This medication is effectively used for the treatment of dyslipidemia.

Dosage and Administration

Adult dosage

Administer once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/10mg∼10/40mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly.

Precautions

This medication is primarily used to lower blood cholesterol levels and contains atorvastatin and ezetimibe. While taking this medication, serious muscle-related side effects such as myopathy or rhabdomyolysis may occur, so if symptoms like muscle pain, weakness, or cramps appear, inform your physician immediately. Patients with conditions that may cause muscle damage, such as severe acute infections, hypotension, major surgery or trauma, and endocrine disorders, should temporarily discontinue or stop this medication. This medication is not administered to patients with compromised liver function, those with muscle diseases, pregnant or potentially pregnant women, nursing mothers, and those taking certain medications. Caution is required when administering to patients with a history of alcoholism or liver disease, and those with impaired kidney function or hypothyroidism, as they are at higher risk for myopathy. This medication may affect liver function; therefore, liver function tests should be performed regularly before and during treatment, and the medication should be stopped if symptoms of liver damage occur. Additionally, this medication may raise blood sugar levels, so patients at risk for diabetes should manage their blood sugar levels closely. There may be drug interactions while taking this medication, particularly with CYP3A4 inhibitors, fibrates, cyclosporine, and antiviral medications, so caution is necessary. Women of childbearing potential should use appropriate contraception while taking this medication and stop immediately if pregnancy is confirmed. There may be symptoms such as dizziness or muscle pain; caution is advised when driving or operating machinery. This medication is not recommended for children as safety and efficacy have not been established, and caution is advised when administering to the elderly due to a higher risk of myopathy. In case of overdose, there is no specific antidote, and appropriate treatment and supportive care should be received based on symptoms while monitoring liver function and muscle enzyme levels. This medication should be stored out of the reach of children and should not be transferred to other containers for safety.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, decreased sensation, dysesthesia, hypertension, increased ALT, increased GGT, nasopharyngitis, cough, itching, dizziness, diabetes, weakness, lethargy, chest pain, peripheral edema, fatigue, fever, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal bloating, dyspepsia, nausea, diarrhea, abdominal pain, vomiting, belching, pancreatitis, pharyngeal and laryngeal pain, epistaxis, insomnia, nightmares, headache, sensory loss, dysgeusia, memory loss, peripheral neuropathy, myalgia, arthralgia, limb pain, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications due to rupture, myopathy, myositis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reactions, anaphylaxis, hepatitis, cholestasis, hepatic failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, hair loss, angioedema, erythema multiforme, mucous membrane syndrome, toxic epidermal necrolysis, gynecomastia, abnormal liver function tests, increased serum creatine kinase, positive urinary leukocytes, nightmares, vomiting, abdominal abnormalities, hepatitis, pancreatitis, cholestasis, cholestatic jaundice, abnormal liver function test results, gastroenteritis, enteritis, dry mouth, rectal bleeding, esophagitis, oral ulcers, stomatitis, gallbladder pain, cheilitis, gastric and duodenal ulcers, dysphagia, melena, gingival bleeding, postprandial urgency, bronchitis, rhinitis, pneumonia, dyspnea, asthma, bradycardia, hypotension, anemia, hernia, hyperkalemia, vitamin D deficiency, gastric polyps, duodenal polyps, duodenitis, jaundice, erectile dysfunction, breast mass, skin mass, ingrown toenails, thyroid adenoma, intracranial aneurysms, restless leg syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, thrombocytopenia, elevated serum creatine kinase levels, myopathy, rhabdomyolysis, increased hepatic aminotransferase levels, hepatitis, thrombocytopenia, nausea, dizziness, dysesthesia, headache, cholelithiasis, cholecystitis, drug-induced liver injury, mucous membrane syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms accompanying drug reactions, erythema multiforme, fatigue, chest pain, chest discomfort, edema, weakness, systemic edema, diabetic neuropathy, tremors, epigastric pain, gastritis, xerostomia, discomfort in the epigastric area, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, frequent urination, cystitis, hematuria, dysuria, nephrolithiasis, nocturia, epididymitis, fibrocystic breast disease, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urgency, abnormal ejaculation, uterine bleeding, discolored urine, increased serum creatine kinase levels, abnormal liver function, hepatitis, jaundice, fulminant hepatitis, mucous membrane syndrome, toxic epidermal necrolysis, hyperhidrosis, rash, itching, upper respiratory tract infection, conjunctival congestion, renal failure, increased blood urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. Additionally, avoid storing in excessively hot or cold environments, and it is recommended to store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.